Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in mice.
about
Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.Anti-TCRβ mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice.Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.
P2860
Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transient combination therapy ...... gs allograft survival in mice.
@en
Transient combination therapy ...... gs allograft survival in mice.
@nl
type
label
Transient combination therapy ...... gs allograft survival in mice.
@en
Transient combination therapy ...... gs allograft survival in mice.
@nl
prefLabel
Transient combination therapy ...... gs allograft survival in mice.
@en
Transient combination therapy ...... gs allograft survival in mice.
@nl
P2093
P2860
P1433
P1476
Transient combination therapy ...... gs allograft survival in mice.
@en
P2093
Mithun Khattar
Paul M Schroder
Ronghai Deng
Stanislaw M Stepkowski
P2860
P304
P356
10.1371/JOURNAL.PONE.0069397
P407
P50
P577
2013-07-24T00:00:00Z